Compare BWFG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWFG | ANGO |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.5M | 420.2M |
| IPO Year | 2014 | 2004 |
| Metric | BWFG | ANGO |
|---|---|---|
| Price | $51.36 | $11.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $55.00 | $18.00 |
| AVG Volume (30 Days) | 31.4K | ★ 253.8K |
| Earning Date | 04-22-2026 | 04-02-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | 81.92 |
| EPS | ★ 1.41 | N/A |
| Revenue | $2,826,000.00 | ★ $291,010,000.00 |
| Revenue This Year | $17.64 | $9.51 |
| Revenue Next Year | $6.21 | $4.96 |
| P/E Ratio | $35.94 | ★ N/A |
| Revenue Growth | ★ 43.96 | 10.17 |
| 52 Week Low | $33.26 | $8.36 |
| 52 Week High | $53.86 | $13.99 |
| Indicator | BWFG | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.35 | 53.05 |
| Support Level | $45.40 | $10.40 |
| Resistance Level | $53.67 | $11.13 |
| Average True Range (ATR) | 1.14 | 0.34 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 38.80 | 62.50 |
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.